The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy

Pediatrics

Volumn 110, Issue 1 I, 2002, Pages 169-171

  Chuansumrit, Ampaiwan ^a   Nuntnarumit, Pracha ^a   Okascharoen, Chusak ^b   Teeraratkul, Sumete ^a   Suwansingh, Saranya ^b   Supapannachart, Sarayut ^a  

^a Department of Pediatrics ^*  (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bleeding; Preterm; rFVIIa

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ARTICLE; BLEEDING; CASE REPORT; CRYOPRECIPITATE; ERYTHROCYTE CONCENTRATE; HEMATOCRIT; HUMAN; LAPAROTOMY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; SURGICAL WOUND; UMBILICAL ARTERY;

BLOOD COAGULATION DISORDERS; DRUG ADMINISTRATION SCHEDULE; FACTOR VII; FACTOR VIIA; HEMATOMA; HEMORRHAGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LAPAROTOMY; MALE; RECOMBINANT PROTEINS; RETROPERITONEAL SPACE; UMBILICAL ARTERIES;

EID: 0036303030     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.1.169     Document Type: Article

References (11)

1. NovoSeven as a universal haemostatic agent
2. The regulation of the factor VII-dependent coagulation pathway: Rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders
3. The factor VIIa-platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
4. Recombinant coagulation factor VIIa: From the concept to clinical application in hemophilia treatment in 2000
5. Clinical efficacy and recovery levels of recombinant factor VIIa (NovoSeven) in the treatment of intracranial hemorrhage in severe neonatal FVII deficiency
6. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation
7. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
8. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa
9. Treatment of traumatic bleeding with recombinant factor VIIa
10. Effect of the administration of recombinant activation factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
11. Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases